These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 26886237)

  • 1. Interactive effects of 9-cis-retinoic acid and androgen on proliferation, differentiation, and apoptosis of LNCaP prostate cancer cells.
    Eskra JN; Kuiper JW; Walden PD; Bosland MC; Özten N
    Eur J Cancer Prev; 2017 Jan; 26(1):71-77. PubMed ID: 26886237
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Control of LNCaP proliferation and differentiation: actions and interactions of androgens, 1alpha,25-dihydroxycholecalciferol, all-trans retinoic acid, 9-cis retinoic acid, and phenylacetate.
    Esquenet M; Swinnen JV; Heyns W; Verhoeven G
    Prostate; 1996 Mar; 28(3):182-94. PubMed ID: 8628721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of retinoic acid on the proliferation and secretory activity of androgen-responsive prostatic carcinoma cells.
    Fong CJ; Sutkowski DM; Braun EJ; Bauer KD; Sherwood ER; Lee C; Kozlowski JM
    J Urol; 1993 May; 149(5):1190-4. PubMed ID: 7683344
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Androgen and retinoic acid interaction in LNCaP cells, effects on cell proliferation and expression of retinoic acid receptors and epidermal growth factor receptor.
    Li MT; Richter F; Chang C; Irwin RJ; Huang H
    BMC Cancer; 2002 Jun; 2():16. PubMed ID: 12069693
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dutasteride, the dual 5alpha-reductase inhibitor, inhibits androgen action and promotes cell death in the LNCaP prostate cancer cell line.
    Lazier CB; Thomas LN; Douglas RC; Vessey JP; Rittmaster RS
    Prostate; 2004 Feb; 58(2):130-44. PubMed ID: 14716738
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antitumoral activity of 13-demethyl or 13-substituted analogues of all-trans retinoic acid and 9-cis retinoic acid in the human myeloid leukemia cell line HL-60.
    Mizuguchi Y; Wada A; Nakagawa K; Ito M; Okano T
    Biol Pharm Bull; 2006 Sep; 29(9):1803-9. PubMed ID: 16946489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 5alpha-androstane-3alpha,17beta-diol supports human prostate cancer cell survival and proliferation through androgen receptor-independent signaling pathways: implication of androgen-independent prostate cancer progression.
    Yang Q; Titus MA; Fung KM; Lin HK
    J Cell Biochem; 2008 Aug; 104(5):1612-24. PubMed ID: 18320593
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The synergistic effects of docetaxol and retinoic acid on prostate cancer cell line PC-3].
    Sun M; Li H; Yang YR; Wei Q; Lu YP; Li X; Li DJ
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2004 Nov; 35(6):797-801. PubMed ID: 15573757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biological effects and metabolism of 9-cis-retinoic acid and its metabolite 9,13-di-cis-retinoic acid in HaCaT keratinocytes in vitro: comparison with all-trans-retinoic acid.
    Chen WC; Sass JO; Seltmann H; Nau H; Orfanos CE; Zouboulis CC
    Arch Dermatol Res; 2000 Dec; 292(12):612-20. PubMed ID: 11214822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Androgens decrease and retinoids increase the expression of insulin-like growth factor-binding protein-3 in LNcaP prostatic adenocarcinoma cells.
    Goossens K; Esquenet M; Swinnen JV; Manin M; Rombauts W; Verhoeven G
    Mol Cell Endocrinol; 1999 Sep; 155(1-2):9-18. PubMed ID: 10580834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New steroidal 17β-carboxy derivatives present anti-5α-reductase activity and anti-proliferative effects in a human androgen-responsive prostate cancer cell line.
    Amaral C; Varela C; Correia-da-Silva G; Tavares da Silva E; Carvalho RA; Costa SC; Cunha SC; Fernandes JO; Teixeira N; Roleira FM
    Biochimie; 2013 Nov; 95(11):2097-106. PubMed ID: 23933094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of compound Chinese traditional medicine PC-SPES II in inhibiting proliferation of human prostate cancer cell LNCaP and on expressions of AR and PSA].
    Zhang BY; Li YF; Lai Y; Li YS; Chen ZJ
    Zhongguo Zhong Yao Za Zhi; 2015 Mar; 40(5):950-6. PubMed ID: 26087562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of androgen receptor by 1alpha,25-dihydroxyvitamin D3 and 9-cis retinoic acid in LNCaP human prostate cancer cells.
    Zhao XY; Ly LH; Peehl DM; Feldman D
    Endocrinology; 1999 Mar; 140(3):1205-12. PubMed ID: 10067845
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activin inhibits basal and androgen-stimulated proliferation and induces apoptosis in the human prostatic cancer cell line, LNCaP.
    Wang QF; Tilly KI; Tilly JL; Preffer F; Schneyer AL; Crowley WF; Sluss PM
    Endocrinology; 1996 Dec; 137(12):5476-83. PubMed ID: 8940374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective Androgen Receptor Modulator S42 Suppresses Prostate Cancer Cell Proliferation.
    Kawanami T; Tanaka T; Hamaguchi Y; Nomiyama T; Nawata H; Yanase T
    Endocrinology; 2018 Apr; 159(4):1774-1792. PubMed ID: 29444261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Androgen receptor signaling and vitamin D receptor action in prostate cancer cells.
    Murthy S; Agoulnik IU; Weigel NL
    Prostate; 2005 Sep; 64(4):362-72. PubMed ID: 15754350
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differentiation-inducing activity of retinoic acid isomers and their oxidized analogs on human promyelocytic leukemia HL-60 cells.
    Matsushima Y; Kawachi E; Tanaka H; Kagechika H; Hashimoto Y; Shudo K
    Biochem Biophys Res Commun; 1992 Dec; 189(2):1136-42. PubMed ID: 1335240
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 6-(3,4-Dihydro-1H-isoquinoline-2-yl)-N-(6-methoxypyridine-2-yl) nicotinamide-26 (DIMN-26) decreases cell proliferation by induction of apoptosis and downregulation of androgen receptor signaling in human prostate cancer cells.
    Choi HE; Shin JS; Leem DG; Kim SD; Cho WJ; Lee KT
    Chem Biol Interact; 2016 Dec; 260():196-207. PubMed ID: 27720946
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiandrogenic effects of novel androgen synthesis inhibitors on hormone-dependent prostate cancer.
    Long BJ; Grigoryev DN; Nnane IP; Liu Y; Ling YZ; Brodie AM
    Cancer Res; 2000 Dec; 60(23):6630-40. PubMed ID: 11118046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 9-cis-retinoic acid signaling in Sertoli cells regulates their immunomodulatory function to control lymphocyte physiology and Treg differentiation.
    Kamińska A; Pardyak L; Lustofin S; Gielata K; Arent Z; Pietsch-Fulbiszewska A; Hejmej A
    Reprod Biol Endocrinol; 2024 Jun; 22(1):75. PubMed ID: 38926848
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.